RESUMEN
OBJECTIVE: To determine the efficacy and reliability of cabergoline and pregnant mare's serum gonadotrophin (PMSG) for induction of oestrus in bitches with primary or secondary anoestrus. PROCEDURES: We studied 39 healthy bitches of various breeds aged 2-6 years and in primary or secondary anoestrus: 20 bitches were administered 5 µg/kg/day cabergoline orally until day 2 after the onset of pro-oestrus or for a maximum of 42 days, and 19 bitches were administered 20 IU/kg/day PMSG intramuscularly for 5 consecutive days, followed by an additional single injection of 25 IU/kg of human chorionic gonadotrophin on the fifth day. RESULTS: The rates of oestrus induction in the primary and secondary anoestrous bitches treated with cabergoline and PMSG were found to be similar. Pregnancy and whelping rates in the cabergoline group were statistically different from the rates in the PMSG group (P < 0.001). CONCLUSION: Cabergoline is more effective and reliable for the induction of a fertile oestrus in bitches with primary or secondary anoestrous.
Asunto(s)
Anestro/efectos de los fármacos , Perros , Ergolinas/uso terapéutico , Gonadotropinas/uso terapéutico , Inducción de la Ovulación/veterinaria , Administración Oral , Animales , Cruzamiento , Cabergolina , Relación Dosis-Respuesta a Droga , Ergolinas/administración & dosificación , Estro/efectos de los fármacos , Estro/fisiología , Femenino , Gonadotropinas/administración & dosificación , Inyecciones Intramusculares/veterinaria , Inducción de la Ovulación/métodos , Embarazo , Índice de EmbarazoRESUMEN
Forty cows between day 1 and day 21 post-calving were examined for the presence of postpartum metritis in a dairy herd that had recently experienced an increase in metritis and that had previously tested positive against bovine herpes virus 4 (BoHV-4) by various methods. Antibodies against BoHV-4 were detected in sera from 15 of 22 cows. For the virological study, uterine swab samples of 22 cows with metritis were used and tested for BoHV-4 using polymerase chain reaction (PCR), virus isolation (VI), and immunofluorescence techniques. Twenty-two point seven per cent (5/22) of the vaginal discharge samples obtained from cows with metritis were found positive for BoHV-4 DNA by PCR. All of these samples were also positive in VI and/or immune fluorescence assay (IF). Swab samples were also tested for bacteria. Empirical therapy with a broad spectrum antibiotic (oxytetracycline) was administrated, pending culture and antibiotic sensitivity result. All cows with puerperal metritis or clinical metritis (CM) were treated with intra-uterine (i.u.) administration of oxytetracycline and with intramuscular (i.m.) injections of dinoprost tromethamine (PGF(2)α) for three consecutive days. Concurrently, with the administration of oxytetracycline and PGF(2)α, cows with a rectal temperature >39.5°C received an additional treatment with oxytetracycline (i.m) for three consecutive days. According to the antibiotic test result, on day 3 after the last oxytetracycline and PGF(2)α administrations, all cows were treated with a combination of amoxicillin and clavulanic acid (i.u.) for three consecutive days. All cows with metritis and that were positive for BoHV-4 recovered clinically after the administration of antibiotic and PGF(2)α. In conclusion, postpartum metritis cases in cows infected BoHV-4 recovered clinically following early diagnosis and prolonged treatments with a combination of antibiotics and PGF(2)α.
Asunto(s)
Bacterias/aislamiento & purificación , Infecciones Bacterianas/veterinaria , Enfermedades de los Bovinos/patología , Dinoprost/análogos & derivados , Infecciones por Herpesviridae/veterinaria , Herpesvirus Bovino 4 , Oxitetraciclina/administración & dosificación , Infección Puerperal/veterinaria , Animales , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Bacterias/inmunología , Infecciones Bacterianas/patología , Bovinos , Enfermedades de los Bovinos/microbiología , Enfermedades de los Bovinos/virología , Dinoprost/administración & dosificación , Dinoprost/uso terapéutico , Femenino , Infecciones por Herpesviridae/sangre , Infecciones por Herpesviridae/complicaciones , Infecciones por Herpesviridae/inmunología , Oxitetraciclina/uso terapéutico , Periodo Posparto/inmunología , Infección Puerperal/microbiología , Infección Puerperal/patología , Infección Puerperal/virología , Turquía , Enfermedades Uterinas/complicaciones , Enfermedades Uterinas/patología , Enfermedades Uterinas/veterinaria , Vagina/microbiología , Vagina/virología , beta-Lactamas/administración & dosificación , beta-Lactamas/uso terapéuticoRESUMEN
The presence of oestrogen-alpha receptor (ER), progesterone receptor (PR), and HER-2/neu (c-erbB-2) oncoprotein in the uterine walls of 10 healthy cats and 20 subjects with cystic endometrial hyperplasia-pyometra (CEH-P) were evaluated. Lesions were graded according to the severity of cystic dilation, hyperplasia and inflammation, and were classified as normal, mild uterine hyperplasia and severe uterine hyperplasia. The ER, PR and c-erbB-2 expression in the endometrium, glandular epithelium, stromal fibroblasts and myometrial smooth muscle cells was quantified by immunohistochemistry. The ER, PR and c-erbB-2 staining patterns differed between normal uteri and uteri with CEH-P. The ER expression was tended to be higher in the endometrial surface and glandular epithelium in the severe hyperplasia group (P > 0.05) and significantly lower in the mild hyperplasia cases compared with normal endometrium (P < 0.05), whereas the PR expression in both severe and mild hyperplasia cases tended to be higher in stromal cells and glandular epithelium than those in the normal uteri. C-erbB-2 immunoreactivity was observed only in the endometrial surface and glandular epithelium of the uterine wall and immunostaining was found to be highest in cases with severe hyperplasia. As a conclusion, we suggest that c-erbB-2 oncoprotein may play a role in the pathogenesis of the CEH together with the ER and PR in cats, and that ER does not have a role in the mechanism of pyometra, whereas PR plays a role in the pathogenesis of both CEH and pyometra.
Asunto(s)
Enfermedades de los Gatos/metabolismo , Hiperplasia Endometrial/veterinaria , Receptor ErbB-2/análisis , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisis , Enfermedades Uterinas/veterinaria , Animales , Enfermedades de los Gatos/patología , Gatos , Hiperplasia Endometrial/metabolismo , Hiperplasia Endometrial/patología , Femenino , Inmunohistoquímica/veterinaria , Índice de Severidad de la Enfermedad , Enfermedades Uterinas/metabolismo , Enfermedades Uterinas/patologíaRESUMEN
Transmissible venereal tumour (TVT) is a coitally transmitted neoplasm of dogs and is common among sexually active dogs, where sexual behaviour is not under control. Several treatment options are available for the treatment of the tumour, with chemotherapy being the most commonly employed. In this study, we investigated the clinical and cytological changes after weekly vincristine sulphate administration in 38 cases of naturally occurring TVT. Tumours totally regressed in 31 dogs after two to seven doses (mean 3.54 +/- 1.01) of vincristine. One dog died after the fifth dose of vincristine, and in six dogs, an additional treatment with doxorubicin was needed. Masses were still present in four dogs and the histopathological examination revealed small nodules of granulation tissue in two dogs, while viable tumour cells were identified in the remaining two cases. No recurrences were observed in a follow-up period of 7-49 months (mean 13.64 +/- 9.66); in one dog, granulation tissue was detected in the surgery site after 2 months. Treatment success could easily be followed by the cytological changes. In conclusion, vincristine was found to be effective chemotherapeutic agent.